The first study, carried out in an orthotopic model of bladder cancer, revealed that the local administration of HP-NAP, by eliciting a potent Th1/Tc1 response, counteracted tumor growth and reduced vascularization of the mass due to the anti-angiogenic activity of IFN-γ (40). The gene discussed is IFNG; the disease is neoplasm.